Keiko Funahashi
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.
Journal: Modern rheumatology
Published: December 06, 2022
Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment.
Journal: Scientific reports
Published: June 12, 2022
A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients.
Journal: Rheumatology advances in practice
Published: May 18, 2022
Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching.
Journal: Modern rheumatology
Published: March 11, 2022
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.
Journal: Frontiers in medicine
Published: December 18, 2020
A genome-wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis.
Journal: Biomedical reports
Published: July 23, 2020
Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis.
Journal: Scientific reports
Published: March 21, 2020
Choice of the most appropriate biological disease-modifying anti-rheumatic drug for injection spacing: results from a multicentre observational study.
Journal: Clinical and experimental rheumatology
Published: November 07, 2018
Whole genome analysis on the genetic backgrounds associated with the secondary failure to etanercept in patients with rheumatoid arthritis.
Journal: Modern rheumatology
Published: July 15, 2016
The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis.
Journal: Modern rheumatology
Published: June 09, 2015
Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population.
Journal: Arthritis research & therapy
Published: July 28, 2014
What RA patients expect of their treatment--discussion over the result of our survey.
Journal: Clinical rheumatology
Published: December 26, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026